Author:
Gelmetti Carlo,Cavalli Riccardo
Publisher
Springer International Publishing
Reference31 articles.
1. Al-Mahdi AH, Al-Sada MA. Assessment of oral propranolol administration for infantile hemangioma in oral and maxillofacial region aided by ultrasonography. J Craniofac Surg. 2020;31(1):189–92.
2. Baselga E, Roe E, Coulie J, Munoz FZ, Boon LM, et al. Risk factors for degree and type of sequelae after involution of untreated hemangiomas of infancy. JAMA Dermatol. 2016;152(11):1239–43.
3. Caussé S, Aubert H, Saint-Jean M, Puzenat E, Bursztejn AC, Eschard C, Mahé E, Maruani A, Mazereeuw-HautierJ DI, Miquel J, Chiaverini C, Boccara O, Hadj-Rabia S, Stalder JF, Barbarot S. Propranolol-resistant infantile haemangiomas. Br J Dermatol. 2013;169(1):125–9.
4. Cavalli R, Buffon RB, de Souza M, Colli AM, GelmettiC. Tumor lysis syndrome after propranolol therapy inulcerative infantile hemangioma: rare complication or incidental finding? Dermatology. 2012;224(2):106–9.
5. Cavalli R, Novotna V, Buffon RB, Gelmetti C. Multiple cutaneous and hepatic infantile hemangiomas having a successful response to propranolol as monotherapy at neonatal period. G Ital Dermatol Venereol. 2013;148(5):525–30.